TWA
AQST icon

TCI Wealth Advisors’s Aquestive Therapeutics AQST Stock Holding History

TCI Wealth Advisors’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-500
Closed -$570 – 334
2023
Q1 		$570 Hold
500
– – ﹤0.01% 2197
2022
Q4 		$451 Hold
500
– – ﹤0.01% 2227
2022
Q3 		$1K Buy
500
+200
+67% +$226 ﹤0.01% 2028
2022
Q2 		$0 Hold
300
– – ﹤0.01% 2267
2022
Q1 		$1K Buy
+300
New +$876 ﹤0.01% 2061

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCI Wealth Advisors's AQST Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Aquestive Therapeutics (AQST) in Q2 2023, closing a stake of 500 shares — an estimated $570 sold.

TCI Wealth Advisors first reported a position in AQST in Q1 2022 and held it in 5 quarters. The position peaked at $1K in Q3 2022. 54 funds tracked by Wall St. Rank hold AQST as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Aquestive Therapeutics position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 500 Aquestive Therapeutics shares in Q2 2023, an estimated $570.
  • TCI Wealth Advisors first reported a position in Aquestive Therapeutics in Q1 2022 and held it in 5 quarters.
  • TCI Wealth Advisors's Aquestive Therapeutics position peaked at $1K in Q3 2022.
  • 54 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.